Filing Details
- Accession Number:
- 0001628280-25-034820
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-11 17:50:41
- Reporting Period:
- 2025-06-02
- Filing Date:
- 2025-07-11
- Accepted Time:
- 2025-07-11 17:50:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1684087 | Caroline Young | 1600 West End Avenue Suite 1300 Nashville TN 37203 | Yes | No | No | No |
Transaction Summary
| Purchased: | 84 shares | Avg. Price: $4.80 | Total Value: $403.60 |
| Number of Shares After Transactions: | 32,653 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-02 | 4 | $5.20 | 32,573 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-03 | 4 | $5.61 | 32,577 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-04 | 4 | $5.75 | 32,581 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-05 | 4 | $5.46 | 32,585 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-06 | 4 | $5.57 | 32,589 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-09 | 4 | $5.94 | 32,593 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-10 | 4 | $6.00 | 32,597 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-11 | 4 | $5.57 | 32,601 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-12 | 4 | $5.67 | 32,605 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-13 | 4 | $5.81 | 32,609 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-16 | 4 | $5.32 | 32,613 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-17 | 4 | $5.61 | 32,617 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-18 | 4 | $5.52 | 32,621 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-20 | 4 | $5.29 | 32,625 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-23 | 4 | $4.61 | 32,629 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-24 | 4 | $3.91 | 32,633 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-25 | 4 | $3.27 | 32,637 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-26 | 4 | $2.71 | 32,641 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-27 | 4 | $2.60 | 32,645 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2025-06-30 | 8 | $2.74 | 32,653 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Footnotes
- The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.
Billionaire Hedge Funds
